External resources For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, dosing calculators, and a community of thousands who have navigated these exact questions
MOTS-c helps your cells actually burn the fat that retatrutide is releasing
The Surging Popularity of GLP-1s By 2024, approximately 4% of Americans were taking a GLP-1 receptor agonist for weight loss, obesity, or type 2 diabetesa staggering 600% increase since 2018
Evening administration aligns with the pineal gland's natural circadian activity
Retatrutide at the 12 mg dose with 24.2% over 48 weeks (TRIUMPH-1, NEJM 2023), followed by tirzepatide at 15 mg with 20.9% over 72 weeks (SURMOUNT-1), then semaglutide at 2.4 mg with 14.9% over 68 weeks (STEP-1)
How Long Should Subjects Remain at Each Retatrutide Dosage Step